381
Participants
Start Date
November 20, 2020
Primary Completion Date
January 20, 2021
Study Completion Date
July 25, 2021
Amyloid Cardiomyopathy
Echocardiographic red flags of Amyloid Cardiomyopathy to guide the suspicion of disease and to proceed with second level diagnostic work up including cardiac scintigraphy with bone tracers and search of monoclonal component in serum and urine
University Cardiology A.O.U., Città della Salute e della Scienza di Torino, Torino
Cardiovascular Unit, Department of Internal Medicine, University of Genova, Genova
Department of medicine and surgery, University Milano-Bicocca, Milan
Department of Cardiovascular, Neural and Metabolic Sciences - Istituto Auxologico Italiano, Milan
Cardiology, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health - University of Brescia, Brescia
Emergency Department and Amyloid Research and Treatment Center, IRCCS Policlinico San Matteo Foundation, Department of Internal Medicine, University of Pavia, Pavia
Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), Trieste
Cardiovascular Department, Policlinico Sant'Orsola, Bologna
Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Ferrara
Cardiomyopathy Unit, Careggi University Hospital, Florence
Division of Cardiology, University of Siena, Siena
Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa
Cardiology Unit, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari
Department of Translational Medical Sciences, Inherited and Rare Heart Disease, Vanvitelli Cardiology, University of Campania Luigi Vanvitelli, Napoli
Department of Cardiology, University of Messina, Messina
Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Roma
Collaborators (1)
Pfizer
INDUSTRY
University of Trieste
OTHER